Suzanne M. Nora Johnson's most recent trade in Intuit Inc was a trade of 880 Common Stock done . Disclosure was reported to the exchange on Jan. 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 880 | 41,733 (0%) | 0% | 0 | Common Stock | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 880 | 0 | - | - | Restricted Stock Units | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 694 | 40,190 (0%) | 0% | 0 | Common Stock | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 694 | 0 | - | - | Restricted Stock Units | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 663 | 40,853 (0%) | 0% | 0 | Common Stock | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 663 | 0 | - | - | Restricted Stock Units | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 586 | 42,882 (0%) | 0% | 0 | Common Stock | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 586 | 0 | - | - | Restricted Stock Units | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 563 | 42,296 (0%) | 0% | 0 | Common Stock | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 563 | 0 | - | - | Restricted Stock Units | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 33 | 42,915 (0%) | 0% | 0 | Common Stock | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 33 | 0 | - | - | Restricted Stock Units | |
| Intuit | Suzanne M. Nora Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 33 | 33 | - | - | Restricted Stock Units | |
| Pfizer | Suzanne M. Nora Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 8,999 | 109,295 | - | - | Phantom Stock Units | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 903 | 0 | - | - | Restricted Stock Units | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 903 | 25,455 (0%) | 0% | 0 | Common Stock | |
| Intuit | Suzanne M. Nora Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 586 | 586 | - | - | Restricted Stock Units | |
| Pfizer | Suzanne M. Nora Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 8,115 | 100,296 | - | - | Phantom Stock Units | |
| Intuit | Nora Johnson Suzanne M. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2024 | 1,215 | 0 | - | - | Restricted Stock Units | |
| Intuit | M. Nora Johnson Suzanne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2024 | 1,215 | 38,593 (0%) | 0% | 0 | Common Stock | |
| Intuit | Suzanne M. Nora Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 563 | 563 | - | - | Restricted Stock Units | |
| Pfizer | Suzanne M. Nora Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 5,291 | 92,181 | - | - | Phantom Stock Units | |
| Intuit | Suzanne M. Nora Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 880 | 880 | - | - | Restricted Stock Unit | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2023 | 1,550 | 37,378 (0%) | 0% | 0 | Common Stock | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2023 | 1,550 | 0 | - | - | Restricted Stock Units | |
| Pfizer | Suzanne M. Nora Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 4,058 | 86,889 | - | - | Phantom Stock Units | |
| Visa | Suzanne M. Nora Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 1,114 | 2,178 (0%) | 0% | 0 | Class A Common Stock | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2022 | 2,220 | 0 | - | - | Restricted Stock Unit | |
| Intuit | Suzanne M. Nora Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2022 | 2,220 | 35,828 (0%) | 0% | 0 | Common Stock | |
| Intuit | Suzanne M. Nora Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 663 | 663 | - | - | Restricted Stock Unit | |
| Pfizer | Suzanne M. Nora Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 4,981 | 82,831 | - | - | Phantom Stock Units |